R3767-ONC-2208 https://www.nct-dresden.de/en/trials/900-000002527 https://www.nct-dresden.de/@@site-logo/logo-nct.svg R3767-ONC-2208 Category Skin tumors Subcategory Melanoma Trial Type other systemic therapies Tumormarkers Description for experts A phase 2 peri-operative Trial of Fianlimab and Cemiplimab compared with Anti-PD1 alone in Patients with resectable stage III and IV melanoma Description for laymen
